Equivocal (HER2 IHC 2+) breast carcinomas: gene ‐protein assay testing reveals association between genetic heterogeneity, individual cell amplification status and potential treatment benefits

Histopathology,Volume 0, Issue ja, -Not available-.

Source: Histopathology - August 16, 2018 Category: Pathology Authors: Gyula Pekar , Ioanna Kasselaki , Agnes P. Lukacs , Csaba Dekany , Dan Hellberg , Tibor Tot Source Type: research